FOXM1 and hepatocellular carcinoma: We evaluated the recurrence-free (Figure 1C) and overall (Figure 1D) survival of these HCC patients and found that FOXM1-high HCC patients showed worse recurrence-free (p = 0.0013) and overall (p = 0.018) survival compared with FOXM1-low HCC patients.